Synthetrial

synthetrial.com ↗ ·Alcalá de Henares ·Pre-seed

Synthetrial is a Spanish deeptech startup that uses generative AI to create synthetic patient data from small samples of real, anonymised patient data, helping pharma, cosmetics and medtech sponsors design, simulate and analyse clinical trials faster and at lower cost. Its models generate 'synthetic patients' that preserve statistically relevant distributions, letting trials reach significance with fewer recruits, predict trial evolution and discard weak research lines earlier. Incorporated as Synthetrial SL in Alcalá de Henares (Madrid) in June 2024, it holds ENISA emerging-company certification and has gone through the healthstart madri+d, RETECH Madrid and Kunsen digital-health acceleration programmes, winning Madrid Impacta 2025 'Social Enterprise of the Year'.

Founded
2024
Founders
2
Total funds raised
—
Rounds
0
SectorsHealthtech & Bio, AI & Data, Clinical trials, Synthetic data, Pharma Start-up MapHealthtech & Bio › Clinical software & health data

Suggest a correction

Founders

José Ignacio Klett Mingo
CEO & Co-founder
Julio Cambronero Plaza
Co-founder

Global models 5

Owkin
Sells AI models built on patient data to pharma sponsors to design and optimise clinical trials, including synthetic and external control arms.
~$300MComparable
Unlearn
United States · www.unlearn.ai ↗
Uses generative AI to build digital-twin synthetic patients, so pharma sponsors can run smaller and faster trials that still reach statistical power, which is the same model as Synthetrial's.
~$135MComparable
Aitia
United States · aitiabio.com ↗
Builds causal AI 'digital twins' of patients from real-world and trial data, and sells simulation of trial outcomes and drug responses to pharma.
~$60MComparable
QuantHealth
Sells AI-based clinical trial simulation to pharma sponsors, predicting trial results in advance so they can drop weak designs and trial candidates early.
~$20MComparable
Syntegra
United States · www.syntegra.io ↗
Used generative AI to create privacy-preserving synthetic patient data from real healthcare records, sold to pharma and life-sciences companies for research and trial analysis.
~$5MComparable

In the same niche 53 others

See all in the Start-ups Map →

Notes: Most funded first

Investors

No investors found yet.

Funding rounds

No announced rounds on record.

News

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list